<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Bird Flu Vaccine News</title>
<link>http://www.inboxrobot.com/news/bird-flu-vaccine</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Medicago announces stock options grant</title>
<link>http://www.inboxrobot.com/news.php?fid=186572617</link>
<pubDate>4 Sep 2008 21:29 GMT</pubDate>
<description>
...  committed to provide highly effective and affordable vaccines based on proprietary Virus-Like Particle (VLP) and  ...  is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system  ...  a transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has  ...
</description>
</item><item>
<title>Ho team makes H5N1 vaccines</title>
<link>http://www.inboxrobot.com/news.php?fid=186537820</link>
<pubDate>4 Sep 2008 17:31 GMT</pubDate>
<description>
... After analyzing hundreds of samples of the avian flu virus, the researchers found a specific gene  ...  genetic composition can be incorporated into a vaccine database to produce new vaccines against the  ...  is found on the surface of all H5N1 viruses and plays a vital role in  ...
</description>
</item><item>
<title>Sinovac Adjourns Annual General Meeting</title>
<link>http://www.inboxrobot.com/news.php?fid=186477384</link>
<pubDate>4 Sep 2008 11:57 GMT</pubDate>
<description>
... , a leading provider of vaccines in China, today announced that its Annual  ...  A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza  ...  Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about  ...
</description>
</item><item>
<title>High Incidence Of Mental Disorders Revealed In Young Offender Institutions</title>
<link>http://www.inboxrobot.com/news.php?fid=186465993</link>
<pubDate>4 Sep 2008 10:58 GMT</pubDate>
<description>
...  diseases (such as malaria, HIV/AIDS, tuberculosis and avian flu) and other prevalent diseases (such as cancer,  ...  led to many exciting developments, including potential vaccines for tuberculosis, malaria and HIV, which are  ...
</description>
</item><item>
<title>The Next Wonder Drug? Just Ask Mother Nature</title>
<link>http://www.inboxrobot.com/news.php?fid=186415071</link>
<pubDate>4 Sep 2008 02:57 GMT</pubDate>
<description>
...  quell viral infections from HIV to the Avian flu. During seasonal epidemics, around 10-20% of the  ...  flu every season. Despite the use of vaccines, the influenza virus is still associated with  ...
</description>
</item><item>
<title>Virologists working on DNA vaccines for H5N1 virus</title>
<link>http://www.inboxrobot.com/news.php?fid=186408950</link>
<pubDate>4 Sep 2008 01:54 GMT</pubDate>
<description>
... Virologists working on DNA vaccines for H5N1 virus TAIPEI, Taiwan -- Scientists at the  ...  genetic information can be incorporated into the vaccine database to produce new vaccines that can  ...  and protected mice against most of the avian flu strains tested,&quot; he said. The newly developed  ...
</description>
</item><item>
<title>GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza</title>
<link>http://www.inboxrobot.com/news.php?fid=186309202</link>
<pubDate>3 Sep 2008 14:35 GMT</pubDate>
<description>
...  century -- in 1918-19, 1957-58, and 1968-69. H5N1 is a subtype of avian flu that some experts believe could lead to  ...  pandemic flu vaccine since 1998, long before bird flu became headline news. Recently, GSK has invested  ...
</description>
</item><item>
<title>Hemispherx Biopharma to Present At BioPharm America Conference Accelerates Commercial Focus With Multiple Registration Targets, Including Vaccine Enhancement</title>
<link>http://www.inboxrobot.com/news.php?fid=186302169</link>
<pubDate>3 Sep 2008 13:57 GMT</pubDate>
<description>
...  Commercial Focus With Multiple Registration Targets, Including Vaccine Enhancement PHILADELPHIA, Sep 3, 2008 (GlobeNewswire via  ...  recently to provide significant immune response to H5N1 highly pathogenic influenza virus (HPIV) in primate  ...
</description>
</item><item>
<title>Hemispherx Biopharma to Present At BioPharm America Conference</title>
<link>http://www.inboxrobot.com/news.php?fid=186298536</link>
<pubDate>3 Sep 2008 13:33 GMT</pubDate>
<description>
...  Commercial Focus With Multiple Registration Targets, Including Vaccine Enhancement PHILADELPHIA, Sept. 3, 2008 (GLOBE NEWSWIRE)  ...  recently to provide significant immune response to H5N1 highly pathogenic influenza virus (HPIV) in primate  ...
</description>
</item><item>
<title>GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockp</title>
<link>http://www.inboxrobot.com/news.php?fid=186291029</link>
<pubDate>3 Sep 2008 12:56 GMT</pubDate>
<description>
...  century -- in 1918-19, 1957-58, and 1968-69. H5N1 is a subtype of avian flu that some experts believe could lead to  ...  pandemic flu vaccine since 1998, long before bird flu became headline news. Recently, GSK has invested  ...
</description>
</item><item>
<title>GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)</title>
<link>http://www.inboxrobot.com/news.php?fid=186288251</link>
<pubDate>3 Sep 2008 12:50 GMT</pubDate>
<description>
...  century -- in 1918-19, 1957-58, and 1968-69. H5N1 is a subtype of avian flu that some experts believe could lead to  ...  pandemic flu vaccine since 1998, long before bird flu became headline news. Recently, GSK has invested  ...
</description>
</item><item>
<title>Sinovac to Present at the Susquehanna Financial Group&apos;s Second Annual Beijing Management Summit Conf</title>
<link>http://www.inboxrobot.com/news.php?fid=186132966</link>
<pubDate>2 Sep 2008 16:33 GMT</pubDate>
<description>
... Sinovac Biotech Ltd. , a vaccine-focused biotech company in China, announced today that  ...  A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza  ...  Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about  ...
</description>
</item><item>
<title>Sinovac to Present at the Susquehanna Financial Group&apos;s Second Annual Beijing Management Summit Conference</title>
<link>http://www.inboxrobot.com/news.php?fid=186098127</link>
<pubDate>2 Sep 2008 13:16 GMT</pubDate>
<description>
...  the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac&apos;s  ...  A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza  ...  Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about  ...
</description>
</item><item>
<title>Aethlon Medical To Present at 2008 Southern California Investor Conference</title>
<link>http://www.inboxrobot.com/news.php?fid=186084233</link>
<pubDate>2 Sep 2008 11:29 GMT</pubDate>
<description>
...  to address the treatment of drug and vaccine resistant viruses. Additionally, the device holds promise  ...  the viruses that constitute pandemic threats, including H5N1 Avian Influenza (bird flu), and Dengue Hemorrhagic Fever (DHF) from circulation.  ...
</description>
</item><item>
<title>Bird flu vaccine gives strong protection in mice</title>
<link>http://www.inboxrobot.com/news.php?fid=186018708</link>
<pubDate>1 Sep 2008 23:53 GMT</pubDate>
<description>
...  have read and accept terms of MediResource&apos;s Bird flu vaccine gives strong protection in mice HONG KONG  ...  uses DNA from various strains of the H5N1 virus appears to trigger a strong immune  ...
</description>
</item></channel>
</rss>
